Amy Franke
Directeur Technique/Scientifique/R&D chez SHATTUCK LABS, INC.
Postes actifs de Amy Franke
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHATTUCK LABS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2022 | - |
Historique de carrière de Amy Franke
Anciens postes connus de Amy Franke
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARAVIVE, INC. | Directeur Technique/Scientifique/R&D | - | 01/08/2022 |
| COVANCE INC. | Corporate Officer/Principal | - | - |
| NERVGEN PHARMA CORP. | Directeur Technique/Scientifique/R&D | 01/04/2019 | - |
Formation de Amy Franke
| University of Pennsylvania Medical Center | Graduate Degree |
| University of Michigan | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Canada | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NERVGEN PHARMA CORP. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Bourse
- Insiders
- Amy Franke
- Expérience
